“My greatest failures are plentiful, though one in particular stands out. I had made the acquaintance of Mr. Hank Greenberg, the former CEO of AIG. He and his family were kind and generous to me.
I offered to do cutting-edge analysis of his health to see if we could offer some helpful, personalized advice, something I felt strongly about because of the man’s great service to the country, some of which is unknown to the public.
I set my team to work and they did a great job making a set of charts and graphics tailored to Mr. Greenberg.
But instead of it taking three weeks it took eight, in part because we have never done this type of deep analysis and because I was also called on to help with a confidential 9/11 forensics project for the city of New York.
David A. Sinclair, Ph.D. : Professor of Genetics at Harvard Medical School
When I received a short email from Mr. Greenberg saying I was too slow and he never wanted to talk to me again, I sent him our analyses and explained the slowness was due in part to the difficulty of the work and a family problem.”
David A. Sinclair, Ph.D. : Professor of Genetics at Harvard Medical School, co-Director and founder of the Paul F. Glenn Laboratories for the Biological Mechanisms of Aging at Harvard Medical School, Professor at the University of New South Wales, and Honorary Professor at the University of Sydney.
He has published 150 papers, is a co-inventor on 40 patents, co-founded ten biotechnology companies in the areas of aging, vaccines, diabetes/cancer, biodefense, forensics and bioinformatics. He serves as co-chief editor of the scientific journal Aging and has received more than 25 awards and honors including the CSL Prize, The Australian Commonwealth Prize, The Frontiers in Aging and Regeneration Award, Top 100 Australian Innovators, and TIME magazine’s list of the “100 most influential people in the world”.